JP2023134519A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023134519A5 JP2023134519A5 JP2023104857A JP2023104857A JP2023134519A5 JP 2023134519 A5 JP2023134519 A5 JP 2023134519A5 JP 2023104857 A JP2023104857 A JP 2023104857A JP 2023104857 A JP2023104857 A JP 2023104857A JP 2023134519 A5 JP2023134519 A5 JP 2023134519A5
- Authority
- JP
- Japan
- Prior art keywords
- methods
- novel products
- manufacture substantially
- manufacture
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025281373A JP2026067872A (ja) | 2017-06-30 | 2025-12-25 | 改変されかつ完全に機能カスタマイズされた糖タンパク質 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762527466P | 2017-06-30 | 2017-06-30 | |
| US62/527,466 | 2017-06-30 | ||
| PCT/EP2018/067494 WO2019002512A2 (en) | 2017-06-30 | 2018-06-28 | GLYCOPROTEINS CUSTOMIZED FROM ENGINEERING AND FULLY FUNCTIONAL |
| JP2019572486A JP7437162B2 (ja) | 2017-06-30 | 2018-06-28 | 改変されかつ完全に機能カスタマイズされた糖タンパク質 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019572486A Division JP7437162B2 (ja) | 2017-06-30 | 2018-06-28 | 改変されかつ完全に機能カスタマイズされた糖タンパク質 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025281373A Division JP2026067872A (ja) | 2017-06-30 | 2025-12-25 | 改変されかつ完全に機能カスタマイズされた糖タンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023134519A JP2023134519A (ja) | 2023-09-27 |
| JP2023134519A5 true JP2023134519A5 (https=) | 2024-02-08 |
Family
ID=62815031
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019572486A Active JP7437162B2 (ja) | 2017-06-30 | 2018-06-28 | 改変されかつ完全に機能カスタマイズされた糖タンパク質 |
| JP2023104857A Pending JP2023134519A (ja) | 2017-06-30 | 2023-06-27 | 改変されかつ完全に機能カスタマイズされた糖タンパク質 |
| JP2025281373A Pending JP2026067872A (ja) | 2017-06-30 | 2025-12-25 | 改変されかつ完全に機能カスタマイズされた糖タンパク質 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019572486A Active JP7437162B2 (ja) | 2017-06-30 | 2018-06-28 | 改変されかつ完全に機能カスタマイズされた糖タンパク質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025281373A Pending JP2026067872A (ja) | 2017-06-30 | 2025-12-25 | 改変されかつ完全に機能カスタマイズされた糖タンパク質 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11913051B2 (https=) |
| EP (1) | EP3645732A2 (https=) |
| JP (3) | JP7437162B2 (https=) |
| KR (2) | KR20240145084A (https=) |
| CN (3) | CN119639577A (https=) |
| AU (1) | AU2018294504B2 (https=) |
| WO (1) | WO2019002512A2 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240145084A (ko) | 2017-06-30 | 2024-10-04 | 림마테크 바이오로직스 아게 | 조작되고 완전-기능 맞춤 당단백질 |
| WO2019234021A1 (en) | 2018-06-04 | 2019-12-12 | Limmatech Biologics Ag | Glycoengineered monoclonal antibody |
| CN111518736B (zh) | 2019-10-24 | 2022-04-15 | 华熙生物科技股份有限公司 | 一种高效合成高纯度透明质酸及其寡聚糖的重组谷氨酸棒状杆菌 |
| WO2021140144A1 (en) | 2020-01-07 | 2021-07-15 | Limmatech Biologics Ag | Engineered leishmania cells |
| JP7684310B2 (ja) * | 2020-01-07 | 2025-05-27 | リンマテック バイオロジクス エージー | Ｌｅｉｓｈｍａｎｉａ細胞を使用する糖鎖修飾改変 |
| EP4161645A4 (en) * | 2020-06-08 | 2023-11-01 | Yale University | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING COAGULOPATHY AND/OR SEPSIS IN PATIENTS WITH BACTERIAL AND/OR VIRAL INFECTIONS |
| WO2022053673A1 (en) | 2020-09-14 | 2022-03-17 | Limmatech Biologics Ag | Fab sialylation of antibodies |
| WO2022200390A2 (en) | 2021-03-23 | 2022-09-29 | Glycoera Ag | Glycan-mediated protein degradation |
| JP2024513755A (ja) | 2021-03-23 | 2024-03-27 | グリコエラ アーゲー | マンノース３グリカン媒介タンパク質分解 |
| JP2024517711A (ja) * | 2021-04-29 | 2024-04-23 | ノバルティス アーゲー | 高シアル酸付加細胞 |
| WO2024068753A1 (en) | 2022-09-28 | 2024-04-04 | Glycoera Ag | Glycan-mediated protein degradation |
| WO2024147113A1 (en) | 2023-01-05 | 2024-07-11 | Glycoera Ag | Glycoengineered polypeptides targeting anti-podocyte autoantibodies and uses thereof |
| JP2026501773A (ja) | 2023-01-05 | 2026-01-16 | グリコエラ アーゲー | 免疫グロブリンａを標的とする糖鎖改変ポリペプチド及びそれを含む複合体 |
| US20260055211A1 (en) | 2023-01-05 | 2026-02-26 | Glycoera Ag | Glycoengineered polypeptides targeting anti-neutrophil autoantibodies and uses thereof |
| WO2024218743A1 (en) | 2023-04-21 | 2024-10-24 | Glycoera Ag | Multi-functional molecules comprising glycans and uses thereof |
| WO2025215516A1 (en) | 2024-04-08 | 2025-10-16 | Glycoera Ag | Glycoengineered polypeptides targeting igg4 autoantibodies and uses thereof |
| TW202602920A (zh) * | 2024-04-26 | 2026-01-16 | 磐石醫藥生技股份有限公司 | 工程化之醣蛋白群體及其用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001032896A1 (en) * | 1999-11-05 | 2001-05-10 | Jena Bioscience Gmbh | Protein expression systems for non-pathogenic <i>kinetoplastidae</i> |
| US7863020B2 (en) * | 2000-06-28 | 2011-01-04 | Glycofi, Inc. | Production of sialylated N-glycans in lower eukaryotes |
| CN107119095B (zh) * | 2008-01-03 | 2022-07-05 | 康乃尔研究基金会有限公司 | 原核生物中的糖基化蛋白表达 |
| JP5652206B2 (ja) | 2008-10-01 | 2015-01-14 | 旭硝子株式会社 | 宿主、形質転換体およびその製造方法、ならびにｏ−グリコシド型糖鎖含有異種蛋白質の製造方法 |
| AU2012329090A1 (en) * | 2011-10-28 | 2014-05-01 | Merck Sharp & Dohme Corp. | Methods for increasing N-glycan occupancy and reducing production of hybrid N-glycans in Pichia pastoris strains lacking Alg3 expression |
| CA3006400A1 (en) | 2015-11-30 | 2017-06-08 | Limmatech Biologics Ag | Methods of producing glycosylated proteins |
| KR20240145084A (ko) | 2017-06-30 | 2024-10-04 | 림마테크 바이오로직스 아게 | 조작되고 완전-기능 맞춤 당단백질 |
| JP7684310B2 (ja) | 2020-01-07 | 2025-05-27 | リンマテック バイオロジクス エージー | Ｌｅｉｓｈｍａｎｉａ細胞を使用する糖鎖修飾改変 |
| WO2021140144A1 (en) | 2020-01-07 | 2021-07-15 | Limmatech Biologics Ag | Engineered leishmania cells |
| WO2022053673A1 (en) | 2020-09-14 | 2022-03-17 | Limmatech Biologics Ag | Fab sialylation of antibodies |
-
2018
- 2018-06-28 KR KR1020247032085A patent/KR20240145084A/ko active Pending
- 2018-06-28 EP EP18736858.4A patent/EP3645732A2/en active Pending
- 2018-06-28 JP JP2019572486A patent/JP7437162B2/ja active Active
- 2018-06-28 KR KR1020207002825A patent/KR102711998B1/ko active Active
- 2018-06-28 AU AU2018294504A patent/AU2018294504B2/en active Active
- 2018-06-28 CN CN202411728767.6A patent/CN119639577A/zh active Pending
- 2018-06-28 CN CN201880056874.5A patent/CN111108211A/zh active Pending
- 2018-06-28 CN CN202310864838.4A patent/CN117487873A/zh active Pending
- 2018-06-28 WO PCT/EP2018/067494 patent/WO2019002512A2/en not_active Ceased
- 2018-06-28 US US16/625,579 patent/US11913051B2/en active Active
-
2023
- 2023-06-27 JP JP2023104857A patent/JP2023134519A/ja active Pending
-
2024
- 2024-01-04 US US18/404,577 patent/US20240287568A1/en active Pending
-
2025
- 2025-12-25 JP JP2025281373A patent/JP2026067872A/ja active Pending